Sellas Life Sciences Group Inc
SLS1.630USD
-0.030-1.81%
交易中 （美東）報價延遲15分鐘
148.15M總市值
虧損本益比TTM
關於 Sellas Life Sciences Group Inc 公司
SELLAS Life Sciences Group, Inc. 是一家後期臨牀生物製藥公司。該公司專注於開發用於治療一系列癌症適應症的新型療法。該公司的候選產品包括 galinpepimut-S (GPS)，一種針對 Wilms 腫瘤 1 (WT1) 抗原的肽免疫療法，以及 SLS009，一種選擇性小分子細胞週期蛋白依賴性激酶 9 (CDK9) 抑制劑。GPS 是一種由紀念斯隆凱特琳癌症中心 (MSK) 授權的癌症免疫治療劑，針對存在於多種腫瘤類型中的 WT1 蛋白。GPS 具有作爲單一療法或與其他免疫治療劑聯合使用的潛力，可以治療廣泛的血液系統惡性腫瘤和實體瘤適應症。該公司正在開發 SLS009，該藥物由 GenFleet Therapeutics (Shanghai), Inc. 授權，用於大中華區以外的全球所有治療和診斷用途。
公司簡介
公司代碼SLS
公司名稱Sellas Life Sciences Group Inc
上市日期Mar 12, 2008
CEODr. Angelos M. Stergiou, M.D.
員工數量15
證券類型Ordinary Share
年結日Mar 12
公司地址7 Times Square
城市NEW YORK
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編10036
電話16462005278
網址https://www.sellaslifesciences.com/
公司代碼SLS
上市日期Mar 12, 2008
CEODr. Angelos M. Stergiou, M.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Angelos M. Stergiou, M.D.
Dr. Angelos M. Stergiou, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
108.88K
-79.44%
Dr. Dragan Cicic, M.D.
Dr. Dragan Cicic, M.D.
Senior Vice President, Chief Development Officer
Senior Vice President, Chief Development Officer
50.33K
-73.28%
Mr. John Thomas Burns, CPA
Mr. John Thomas Burns, CPA
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
48.60K
-77.19%
Ms. Jane Wasman, J.D.
Ms. Jane Wasman, J.D.
Independent Director
Independent Director
30.40K
+192.31%
Ms. Katherine Bach Kalin
Ms. Katherine Bach Kalin
Independent Director
Independent Director
30.40K
+192.31%
Mr. Robert L. Van Nostrand, CPA
Mr. Robert L. Van Nostrand, CPA
Independent Director
Independent Director
20.40K
+96.15%
Dr. David A. Scheinberg, M.D., Ph.D.
Dr. David A. Scheinberg, M.D., Ph.D.
Independent Director
Independent Director
10.58K
-38.05%
Mr. John W. Varian
Mr. John W. Varian
Independent Chairman of the Board
Independent Chairman of the Board
10.40K
-38.46%
名稱
名稱/職務
職務
持股
持股變動
Dr. Angelos M. Stergiou, M.D.
Dr. Angelos M. Stergiou, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
108.88K
-79.44%
Dr. Dragan Cicic, M.D.
Dr. Dragan Cicic, M.D.
Senior Vice President, Chief Development Officer
Senior Vice President, Chief Development Officer
50.33K
-73.28%
Mr. John Thomas Burns, CPA
Mr. John Thomas Burns, CPA
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
48.60K
-77.19%
Ms. Jane Wasman, J.D.
Ms. Jane Wasman, J.D.
Independent Director
Independent Director
30.40K
+192.31%
Ms. Katherine Bach Kalin
Ms. Katherine Bach Kalin
Independent Director
Independent Director
30.40K
+192.31%
Mr. Robert L. Van Nostrand, CPA
Mr. Robert L. Van Nostrand, CPA
Independent Director
Independent Director
20.40K
+96.15%
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 7月23日 週三
更新時間: 7月23日 週三
持股股東
股東類型
持股股東
持股股東
佔比
Anson Funds Management LP.
7.60%
The Vanguard Group, Inc.
2.85%
Geode Capital Management, L.L.C.
0.82%
Susquehanna International Group, LLP
0.69%
BlackRock Institutional Trust Company, N.A.
0.44%
Other
87.61%
持股股東
持股股東
佔比
Anson Funds Management LP.
7.60%
The Vanguard Group, Inc.
2.85%
Geode Capital Management, L.L.C.
0.82%
Susquehanna International Group, LLP
0.69%
BlackRock Institutional Trust Company, N.A.
0.44%
Other
87.61%
股東類型
持股股東
佔比
Hedge Fund
8.57%
Investment Advisor
4.65%
Investment Advisor/Hedge Fund
1.39%
Individual Investor
0.33%
Research Firm
0.19%
Bank and Trust
0.05%
Other
84.82%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
94
15.15M
15.18%
+3.74M
2025Q1
95
15.37M
15.79%
+4.85M
2024Q4
82
6.32M
8.71%
-3.29M
2024Q3
79
5.54M
8.62%
-2.91M
2024Q2
81
6.60M
15.25%
-2.78M
2024Q1
80
10.46M
22.59%
+5.00M
2023Q4
78
5.95M
19.06%
+1.91M
2023Q3
79
3.15M
11.52%
-1.61M
2023Q2
83
3.51M
12.82%
-1.46M
2023Q1
86
3.47M
12.66%
-413.28K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Anson Funds Management LP.
7.58M
7.6%
+6.39M
+535.69%
Mar 31, 2025
The Vanguard Group, Inc.
2.84M
2.85%
+546.46K
+23.83%
Mar 31, 2025
Geode Capital Management, L.L.C.
820.44K
0.82%
+86.89K
+11.85%
Mar 31, 2025
Susquehanna International Group, LLP
688.70K
0.69%
+688.70K
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
436.33K
0.44%
+3.52K
+0.81%
Mar 31, 2025
Citadel Advisors LLC
349.50K
0.35%
-135.81K
-27.98%
Mar 31, 2025
State Street Global Advisors (US)
277.03K
0.28%
+49.30K
+21.65%
Mar 31, 2025
Opus Capital Management, Inc.
239.50K
0.24%
+1.00K
+0.42%
Mar 31, 2025
Northern Trust Investments, Inc.
164.39K
0.16%
+29.70K
+22.05%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.04%
ProShares UltraPro Russell2000
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
佔比0.04%
ProShares UltraPro Russell2000
佔比0.01%
ProShares Hedge Replication ETF
佔比0.01%
iShares Russell 2000 ETF
佔比0.01%
iShares Russell 2000 Growth ETF
佔比0.01%
Global X Russell 2000 ETF
佔比0.01%
Proshares Ultra Russell 2000
佔比0.01%
iShares Core S&P Total U.S. Stock Market ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
